Shin Nippon Biomedical Laboratories, Ltd. Stock
Equities
2395
JP3379950003
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,447 JPY | -2.43% | -2.95% | -14.78% |
Sales 2024 * | 26.19B 170M | Sales 2025 * | 31.5B 204M | Capitalization | 61.74B 400M |
---|---|---|---|---|---|
Net income 2024 * | 3.98B 25.74M | Net income 2025 * | 5.3B 34.32M | EV / Sales 2024 * | 3.1 x |
Net Debt 2024 * | 19.51B 126M | Net Debt 2025 * | 18.93B 123M | EV / Sales 2025 * | 2.56 x |
P/E ratio 2024 * |
15.5
x | P/E ratio 2025 * |
11.6
x | Employees | 1,344 |
Yield 2024 * |
3.37% | Yield 2025 * |
3.37% | Free-Float | 48.8% |
1 day | -2.43% | ||
1 week | -2.95% | ||
Current month | -4.68% | ||
1 month | -5.55% | ||
3 months | -15.28% | ||
6 months | -14.78% | ||
Current year | -14.78% |
Managers | Title | Age | Since |
---|---|---|---|
Ryoichi Nagata
CEO | Chief Executive Officer | 65 | 81-08-31 |
Shinji Nitanda
DFI | Director of Finance/CFO | 55 | 02-04-30 |
Terumasa Hirai
CMP | Compliance Officer | - | 84-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ichiro Nagata
BRD | Director/Board Member | 38 | 17-03-31 |
Sales & Marketing | 64 | 02-10-31 | |
Ken Takanashi
COO | Chief Operating Officer | 59 | 02-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.51% | 23 M€ | +0.14% | - | |
0.08% | 19 M€ | +0.95% | ||
0.01% | 18 M€ | +16.15% | - | |
0.01% | 144,586 M€ | +11.90% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 1,447 | -2.43% | 62 200 |
24-04-18 | 1,483 | +1.78% | 187,400 |
24-04-17 | 1,457 | +0.41% | 162,000 |
24-04-16 | 1,451 | -1.89% | 187,500 |
24-04-15 | 1,479 | -0.80% | 141,500 |
Delayed Quote Japan Exchange, April 18, 2024 at 09:21 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.78% | 392M | |
-1.82% | 41.36B | |
+44.25% | 41.3B | |
+2.56% | 39.61B | |
-12.11% | 25.62B | |
+3.09% | 24.09B | |
-24.16% | 18.38B | |
+22.12% | 11.85B | |
-3.74% | 11.82B | |
+7.75% | 11.07B |
- Stock Market
- Equities
- 2395 Stock